Acute and Chronic Nicotine Exposures Differentially Affect Central Serotonin 2A Receptor Function: Focus on the Lateral Habenula.
5-HT2CR
addiction
dentate gyrus
depression
dorsal raphe nucleus
medial prefrontal cortex
nucleus accumbens
striatum
substantia nigra pars compacta
ventral tegmental area
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
09 Mar 2020
09 Mar 2020
Historique:
received:
03
02
2020
accepted:
06
03
2020
entrez:
19
3
2020
pubmed:
19
3
2020
medline:
15
12
2020
Statut:
epublish
Résumé
Nicotine addiction is a serious public health problem causing millions of deaths worldwide. Serotonin (5-hydroxytryptamine; 5-HT) is involved in central nervous system (CNS) nicotine effects, and it has been suggested as a promising pharmacological target for smoking cessation. In this regard, what is particularly interesting are the 5-HT
Identifiants
pubmed: 32182934
pii: ijms21051873
doi: 10.3390/ijms21051873
pmc: PMC7084359
pii:
doi:
Substances chimiques
Receptor, Serotonin, 5-HT2A
0
Serotonin
333DO1RDJY
Nicotine
6M3C89ZY6R
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
CNS Neurosci Ther. 2018 Aug;24(8):721-733
pubmed: 29479825
Exp Brain Res. 2013 Oct;230(4):427-39
pubmed: 23591691
Cold Spring Harb Perspect Med. 2013 Jun 01;3(6):
pubmed: 23732855
Neuropharmacology. 2018 Nov;142:20-29
pubmed: 28987938
Front Neurosci. 2010 Aug 13;4:
pubmed: 20802802
Neuroscience. 1999;91(2):587-97
pubmed: 10366016
Neurochem Res. 2004 Sep;29(9):1779-92
pubmed: 15453274
Sci Rep. 2016 Sep 06;6:32937
pubmed: 27596561
J Med Chem. 2006 Sep 21;49(19):5794-803
pubmed: 16970404
Brain Struct Funct. 2016 Dec;221(9):4663-4689
pubmed: 26888156
CNS Neurosci Ther. 2010 Jun;16(3):127-36
pubmed: 20345972
Psychopharmacology (Berl). 2006 Mar;184(3-4):274-85
pubmed: 16362402
Neuropharmacology. 2014 Jan;76 Pt B:533-44
pubmed: 24055497
Psychopharmacology (Berl). 2001 Sep;157(3):292-8
pubmed: 11605085
Neuropharmacology. 2012 Jun;62(7):2288-98
pubmed: 22342986
Neuropsychopharmacology. 2011 Feb;36(3):589-602
pubmed: 21048703
J Comp Neurol. 1999 Jun 28;409(2):187-209
pubmed: 10379914
Brain Res Bull. 2016 Mar;121:1-8
pubmed: 26589642
Physiol Behav. 2016 Mar 1;155:162-71
pubmed: 26687895
Philos Trans R Soc Lond B Biol Sci. 2009 Apr 12;364(1519):1005-20
pubmed: 19064356
J Comp Neurol. 1986 Jun 1;248(1):1-18
pubmed: 2873154
Curr Pharm Des. 2007;13(12):1269-84
pubmed: 17504235
Psychopharmacology (Berl). 1997 Oct;133(4):343-6
pubmed: 9372532
Psychopharmacology (Berl). 2005 May;179(2):393-401
pubmed: 15565434
Pharmacol Biochem Behav. 2017 Nov;162:22-28
pubmed: 28528079
Neuropharmacology. 2013 Jan;64:403-13
pubmed: 22722027
Psychopharmacology (Berl). 2018 Oct;235(10):2809-2822
pubmed: 30027497
Synapse. 2010 Jul;64(7):511-9
pubmed: 20196140
Psychopharmacology (Berl). 1995 Jan;117(1):2-10; discussion 14-20
pubmed: 7724697
Psychopharmacology (Berl). 1992;107(2-3):285-9
pubmed: 1615127
Pharmacol Biochem Behav. 2005 Oct;82(2):289-92
pubmed: 16185760
Rev Neurosci. 2013;24(6):629-64
pubmed: 24259245
Eur J Pharmacol. 2000 Mar 30;393(1-3):295-314
pubmed: 10771025
Rev Neurosci. 2013;24(5):455-69
pubmed: 24021594
Pharmacol Ther. 2016 Jan;157:125-62
pubmed: 26617215
Curr Pharm Des. 2010;16(23):2510-7
pubmed: 20550508
Neuroscience. 2007 Feb 23;144(4):1523-35
pubmed: 17161544
J Neurosci. 2013 Oct 2;33(40):15716-25
pubmed: 24089480
Eur J Neurosci. 2011 May;33(10):1866-75
pubmed: 21501256
Sci Rep. 2016 Apr 01;6:23798
pubmed: 27033153
J Neurosci. 2014 Mar 19;34(12):4273-84
pubmed: 24647947
Neuropharmacology. 2010 Jun;58(7):1140-6
pubmed: 20153341
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109731
pubmed: 31394140
Prog Brain Res. 2008;172:361-83
pubmed: 18772042
ACS Chem Neurosci. 2015 Jul 15;6(7):1071-88
pubmed: 25870913
Neuroscience. 2015 Jun 25;297:22-37
pubmed: 25818050
Neurosci Lett. 2019 Nov 20;713:134524
pubmed: 31585211
J Neurochem. 2015 Aug;134(4):704-16
pubmed: 26031442
Psychopharmacology (Berl). 2005 May;179(3):521-8
pubmed: 15682310
Eur J Pharmacol. 2007 Oct 1;571(2-3):156-65
pubmed: 17617403
J Pharmacol Exp Ther. 2004 Apr;309(1):109-18
pubmed: 14722316
Front Synaptic Neurosci. 2016 Oct 24;8:34
pubmed: 27822183
Neuropharmacology. 2016 Sep;108:292-304
pubmed: 27085605
Pharmacol Rep. 2015 Jun;67(3):451-9
pubmed: 25933953
Neuropharmacology. 2016 Feb;101:449-59
pubmed: 26471419
Prog Neurobiol. 2017 Apr;151:175-236
pubmed: 27013075
J Pharmacol Exp Ther. 1988 Jan;244(1):310-21
pubmed: 3336007
J Neurobiol. 1994 Feb;25(2):143-55
pubmed: 7517436
Neuropsychopharmacology. 2007 Dec;32(12):2441-52
pubmed: 17356570
Front Cell Neurosci. 2015 Jun 01;9:197
pubmed: 26082682
Eur J Pharmacol. 2001 May 18;420(1):45-54
pubmed: 11412838
Front Hum Neurosci. 2014 Mar 28;8:174
pubmed: 24734015
Front Synaptic Neurosci. 2018 May 29;10:12
pubmed: 29896097